Weight loss injections have reshaped the scene of obesity treatment. Mounjaro and Wegovy stand out as the top weight loss injections available today. Recent head-to-head clinical trials show Mounjaro (tirzepatide) delivers substantially better results. People with obesity lost 20.2% of their body weight on Mounjaro compared to 13.7% with Wegovy (semaglutide).

The best weight loss injections in the UK show dramatic differences that matter. Mounjaro users saw their waistlines shrink by 18cm while Wegovy users lost 13cm. The highest dose of Mounjaro helped people lose up to 22.5% of their body weight. This makes it the most effective weight loss injection available. The results are remarkable. 32% of people using Mounjaro lost a quarter of their body weight. Wegovy achieved this milestone in just 16% of users.

Mounjaro emerges as the best injection for weight loss based on current evidence. It consistently performs better than Wegovy in multiple ways. But both medications work well. Wegovy users still lost an average of 14.9% of their weight over 68 weeks. This detailed comparison will get into how these breakthrough treatments work. You’ll learn about their clinical results, side effects, and UK costs to help you decide which option fits your needs.

Mechanism of action: How Mounjaro and Wegovy work differently

These two best weight loss injections work differently in the body. Learning about their mechanisms helps us understand why they work differently in clinical settings.

Hormonal Targets: GLP-1 vs GLP-1 + GIP

Mounjaro and Wegovy mimic the hormones your body releases after eating, but there’s a vital difference. Wegovy (semaglutide) works with just one hormone pathway by mimicking GLP-1 (glucagon-like peptide-1). Mounjaro (tirzepatide) works with two hormone pathways – it targets both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors. This two-pronged approach gives Mounjaro an edge in weight management.

Appetite suppression and satiety effects

We noticed these medications affect how full you feel after meals. They signal your brain that you’re full, which leads to eating less. Your digestion slows down because food stays in your stomach longer. This makes your brain receive stronger signals about being full.

Patients who take Mounjaro report feeling less hungry even when starting with lower doses. They feel satisfied faster during meals and eat less food naturally.

Impact on fat storage and metabolism

These medications do more than control appetite. they change how your body handles and stores fat. Wegovy works by reducing hunger and slowing digestion, so you eat fewer calories. Mounjaro takes this further. It not only reduces appetite but also helps your body burn stored fat for energy.

On top of that, Mounjaro works well against visceral fat (the dangerous fat around your organs). This fat type links strongly to diabetes and heart problems. The medication’s dual approach boosts insulin sensitivity and improves fat burning, making it possibly the best weight loss injection available today.

Weight loss results from clinical trials

Clinical trials show which medication works better for weight loss. The data reveals significant differences between these two leading weight loss injections.

SURMOUNT-1 vs STEP-1: 22.5% vs 17% weight loss

The groundbreaking SURMOUNT-1 trial for Mounjaro and STEP-1 trial for Wegovy prove their effectiveness, with clear differences between them. Patients who took the maximum dose of Mounjaro lost an impressive 20.9-22.5% of their body weight over 72 weeks. This is a big deal as it means that Mounjaro outperformed Wegovy’s 15-17% weight loss during the same period.

The SURMOUNT-5 trial compared both medications directly and confirmed better results with Mounjaro. Users lost 20.2% of their body weight compared to 13.7% with Wegovy. A trial investigator noted, “The majority of people with obesity will do fine with semaglutide, those at the higher end may do better with tirzepatide”.

Waist circumference reduction: 18cm vs 13cm

Waist circumference reduction is a vital indicator of better metabolic health. Mounjaro users saw their waist shrink by an average of 18.4cm, while Wegovy users achieved a 13cm reduction. The extra 5cm decrease shows meaningful improvement in abdominal obesity, which often links to metabolic complications.

Percentage of users losing 15%+ body weight

The number of patients reaching significant weight loss milestones shows the most dramatic contrast. Mounjaro helped 83.7% of users lose at least 15% of their weight, while 56.2% of Wegovy users reached this goal. The results get even more impressive: 57% of people taking Mounjaro dropped over 20% of their body weight, compared to 35% with Wegovy.

The most striking result shows that 32% of Mounjaro patients lost at least 25% of their starting weight; double the number of Wegovy users who reached this milestone at 16%.

Side effects and tolerability

Understanding the potential side effects plays a vital role in making informed decisions about the best weight loss injections.

Common side effects: Nausea, diarrhoea, constipation

Mounjaro and Wegovy show remarkably similar side effect patterns that mainly affect the digestive system. Users most commonly report nausea, diarrhoea, constipation, vomiting and abdominal pain. These digestive symptoms usually show up during the first weeks of treatment or after increasing doses. Each person’s experience varies, and most patients have mild to moderate symptoms that get better as their bodies adapt to the medication.

Discontinuation rates: 6% Mounjaro vs 8% Wegovy

Mounjaro shows a slight edge in keeping patients on treatment, despite having similar side effects. Clinical trials reveal that about 6.2% of patients quit Mounjaro at the 15mg dose because of adverse events, while Wegovy saw an 8% dropout rate. About half of all users stop within a year, mostly due to stomach issues or cost. Wegovy’s highest 7.2mg dose had a 5.4% dropout rate, that indicates tolerance levels change across different doses.

Long-term safety considerations

We still don’t have enough data about long-term safety for both medications. Rare but serious complications can include pancreatitis, severe allergic reactions, gallbladder problems and thyroid issues. Research shows users face 2.5 times higher risk of developing drug-induced acute pancreatitis. The weight comes back four times faster after stopping these injections compared to traditional diets. This rapid weight regain happens to many patients who stop either medication.

Cost and accessibility in the UK

Money matters a lot when picking between these best weight loss injections. The costs and availability are quite different across the UK.

Price comparison by dosage tier

Private prescription costs vary based on dosage tier. Wegovy costs from £99 (0.25mg starting dose) to £239 (2.4mg maintenance dose) per monthly pen. Mounjaro is a bit more expensive, with prices from £149-£179 (2.5mg starting dose) to £299-£360 (15mg maintenance dose). The prices change between providers, and most online pharmacies offer better rates than traditional clinics.

Annual cost: £3,277 vs £2,147

The yearly costs are very different. A full year of Mounjaro costs £3,149-£3,292 at maintenance doses, while Wegovy costs around £2,671. So over two years, patients might pay about £6,509-£6,880 for Mounjaro compared to £5,719 for Wegovy.

Availability via NHS and private clinics

The NHS has very limited access. You can only get these medications through specialised tier 3 weight management services with strict rules. Patients need a BMI of at least 40 plus four weight-related health conditions to qualify. Private options include online pharmacies, specialist weight clinics, and traditional private hospitals.

Support packages and online services

Beyond medication costs, many providers offer detailed support. The first consultation costs between £50-£150, and ongoing support packages have different prices. These packages often include dietitian services (£56-£150 per session), psychological support (£130-£140 per session), and regular health monitoring. Online services often combine these supports with medication costs to make pricing simpler.

Cheapest Mounjaro in the UK

Annual costs at maintenance doses:

• Mounjaro (cheapest Mounjaro in UK): £3,072 per year (£256/month)
  
• Wegovy (standard price): £3,168 per year (£264/month)
  

With the special price, Mounjaro becomes £96 per year cheaper than Wegovy.

Comparison table

Takeaway

Clinical trials show Mounjaro is the most powerful weight loss injection available today. Its effectiveness comes from targeting both GLP-1 and GIP hormones, which helps users lose by a lot more weight than Wegovy (20.2% versus 13.7%). The results are impressive – patients see better waist size reduction and reach their weight loss goals faster.

Both medications have similar side effects, but Mounjaro has a slight edge as fewer people stop using it. Your choice between these treatments often comes down to results versus cost. Wegovy costs about £2,671 per year, while Mounjaro ranges from £3,149 to £3,292, making Wegovy a good choice for budget-friendly results.

The UK’s NHS has strict rules about who can get these medications through specialised services. Most patients need to look at private treatment options whatever medication they choose.

The best injection for your weight loss experience depends on three things: your health goals, your budget, and your body’s response to treatment. Mounjaro gives better results based on current evidence, but Wegovy still works much better than traditional weight loss methods. Talk to your healthcare provider about these options to find what works best for your situation and goals.

Zuella Montemayor, a psychology graduate from the University of Hertfordshire, has a keen interest in the fields of mental health, wellness, and lifestyle.